ProQR Therapeutics N.V. (PRQR)
NASDAQ: PRQR
· Real-Time Price · USD
2.04
0.02 (0.99%)
At close: Aug 15, 2025, 3:59 PM
2.05
0.24%
After-hours: Aug 15, 2025, 04:10 PM EDT
ProQR Therapeutics Income Statement
Financials in EUR. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 19.01M | 18.96M | 17.86M | 15.38M | 10.25M | 6.43M | 4.05M | 3.64M | 3.46M | 4.04M | 3.45M | 3.37M | 2.59M | 1.35M | 1.11M | 243K | n/a |
Cost of Revenue | 714.6K | 1.41M | 1.41M | 1.41M | 695.07K | n/a | 712.92K | 712.92K | 712.92K | 712.92K | n/a | n/a | n/a | 646.67K | 646.67K | 646.67K | 646.67K |
Gross Profit | 18.29M | 17.55M | 16.45M | 13.97M | 9.56M | 6.43M | 3.34M | 2.93M | 2.75M | 3.32M | 3.45M | 3.37M | 2.59M | 707.33K | 468.33K | -403.67K | -646.67K |
Operating Income | -33.39M | -30.91M | -29.79M | -28.46M | -33.5M | -34.55M | -37.95M | -50.24M | -57.16M | -64.72M | -69.69M | -64.56M | -62.03M | -57.19M | -51.53M | -47.84M | -37.99M |
Interest Income | 515.59K | 1.01M | 1.83M | 2.2M | 2.16M | 1.67M | 1.42M | 1.04M | 575.67K | 575.67K | -890K | -890K | -890K | -890K | 313K | 313K | 313K |
Pretax Income | -30.38M | -28.01M | -24.04M | -21.39M | -26.52M | -27.67M | -33.73M | -52.58M | -59.21M | -64.8M | -71.62M | -62.34M | -63.4M | -61.56M | -56.53M | -54.62M | -43.02M |
Net Income | -30.18M | -27.81M | -23.85M | -21.45M | -26.75M | -27.04M | -32.33M | -51M | -57.67M | -64.13M | -71.72M | -62.39M | -63.46M | -61.62M | -56.62M | -54.75M | -43.12M |
Selling & General & Admin | 13.44M | 12.99M | 12.99M | 13.02M | 14.16M | 15.4M | 14.46M | 16.5M | 17.77M | 18.65M | 21M | 20.23M | 18.94M | 17.37M | 15.56M | 13.78M | 13.11M |
Research & Development | 39.4M | 36.41M | 33.33M | 29.37M | 28.23M | 24.95M | 28.11M | 38.02M | 43.56M | 50.87M | 52.62M | 48.4M | 46.68M | 42.22M | 38.18M | 35.36M | 34.22M |
Other Expenses | -652K | -498K | -418K | -280K | -124K | -98K | -807K | -728K | -567K | -626K | 139K | 60K | -101K | -729K | -729K | -1.03M | -1M |
Operating Expenses | 52.19M | 48.97M | 46.03M | 42.23M | 42.38M | 40.31M | 41.77M | 53.72M | 60.52M | 68.65M | 73.52M | 68.52M | 65.52M | 59.45M | 53.61M | 48.75M | 38.26M |
Interest Expense | 2.59K | 5.47K | -271.24K | -260.68K | -264.31K | -267.18K | 748.52K | 737.97K | 739K | 739K | 19K | 19K | 19K | 19K | 16K | 1.88M | 1.88M |
Selling & Marketing Expenses | n/a | -674.75K | -1.51M | -1.51M | -1.51M | -831.2K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 52.34M | 49.82M | 47.59M | 43.79M | 43.79M | 41.02M | 41.77M | 53.72M | 60.52M | 68.65M | 73.52M | 68.52M | 65.52M | 59.45M | 53.61M | 48.75M | 38.26M |
Income Tax Expense | -200K | -196.98K | -192.11K | -233.11K | -75.11K | -942.13K | -1.71M | -1.59M | -1.53M | -662K | 118K | 84K | 117K | 117K | 133K | 173K | 131K |
Shares Outstanding (Basic) | 105.3M | 81.67M | 81.67M | 81.67M | 81.57M | 78.46M | 81M | 80.94M | 80.89M | 77.39M | 71.38M | 71.36M | 71.36M | 71.24M | 68.26M | 66.15M | 50.81M |
Shares Outstanding (Diluted) | 105.3M | 81.67M | 81.67M | 81.67M | 81.57M | 78.46M | 81M | 80.94M | 80.89M | 77.39M | 71.38M | 71.36M | 71.36M | 71.24M | 68.26M | 66.15M | 50.81M |
EPS (Basic) | -0.34 | -0.34 | -0.29 | -0.27 | -0.33 | -0.34 | -0.41 | -0.68 | -0.79 | -0.89 | -1.01 | -0.89 | -0.92 | -0.97 | -0.97 | -1.01 | -0.85 |
EPS (Diluted) | -0.34 | -0.34 | -0.29 | -0.27 | -0.33 | -0.34 | -0.41 | -0.68 | -0.79 | -0.89 | -1.01 | -0.89 | -0.92 | -0.97 | -0.97 | -1.01 | -0.85 |
EBITDA | -27.17M | -24.42M | -26.85M | -25.43M | -30.64M | -32.1M | -30.13M | -42.67M | -49.75M | -57.39M | -68.84M | -63.86M | -61.53M | -56.53M | -51.3M | -47.47M | -37.28M |
EBIT | -29.92M | -27.18M | -21.7M | -20.24M | -25.33M | -26.65M | -32.66M | -45.17M | -52.25M | -59.91M | -71.17M | -66.11M | -63.8M | -58.85M | -53.73M | -50M | -48.42M |
Depreciation & Amortization | 2.75M | 2.77M | 2.8M | 2.78M | 2.66M | 2.51M | 2.51M | 2.48M | 2.49M | 2.52M | 2.36M | 2.29M | 2.3M | 2.37M | 2.46M | 2.56M | 2.48M |